Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis (Q46286038)
Jump to navigation
Jump to search
scientific article published on 2 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis |
scientific article published on 2 June 2013 |
Statements
1 reference
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis (English)
1 reference
William J Sandborn
1 reference
Brian G Feagan
1 reference
Paul Rutgeerts
1 reference
Jean-Frederic Colombel
1 reference
Walter Reinisch
1 reference
Toshifumi Hibi
1 reference
Colleen Marano
1 reference
Omoniyi J Adedokun
1 reference
Cynthia Guzzo
1 reference
Gunnar Järnerot
1 reference
Hongyan Zhang
1 reference
Richard Strauss
1 reference
Jewel Johanns
1 reference
Peter R Gibson
1 reference
Judith Collins
1 reference
PURSUIT-SC Study Group
1 reference
2 June 2013
1 reference
1 reference
146
1 reference
1
1 reference
85-95; quiz e14-5
1 reference